Cargando…
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis
Introduction: With the increasing use of immune checkpoint inhibitors (ICI) for cancer, there is a growing burden on the healthcare system to provide care for the toxicities associated with these agents. Herein, we aim to identify and describe the distribution of encounters seen in an urgent care se...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221771/ https://www.ncbi.nlm.nih.gov/pubmed/35735456 http://dx.doi.org/10.3390/curroncol29060347 |
_version_ | 1784732705160691712 |
---|---|
author | Liang, Kai-li Tackett, Sean Myers, Samantha Brahmer, Julie R. Browner, Ilene S. Ettinger, David S. Forde, Patrick M. Hales, Russell K. Hann, Christine L. Lam, Vincent K. Marrone, Kristen A. Patel, Tricia Peterson, Valerie Sagorsky, Sarah Turner, Michelle Voong, Khinh R. Naidoo, Jarushka Feliciano, Josephine L. |
author_facet | Liang, Kai-li Tackett, Sean Myers, Samantha Brahmer, Julie R. Browner, Ilene S. Ettinger, David S. Forde, Patrick M. Hales, Russell K. Hann, Christine L. Lam, Vincent K. Marrone, Kristen A. Patel, Tricia Peterson, Valerie Sagorsky, Sarah Turner, Michelle Voong, Khinh R. Naidoo, Jarushka Feliciano, Josephine L. |
author_sort | Liang, Kai-li |
collection | PubMed |
description | Introduction: With the increasing use of immune checkpoint inhibitors (ICI) for cancer, there is a growing burden on the healthcare system to provide care for the toxicities associated with these agents. Herein, we aim to identify and describe the distribution of encounters seen in an urgent care setting for immune-related adverse events (irAEs) and the clinical outcomes from irAE management. Methods: Patient demographics, disease characteristics, and treatment data were collected retrospectively from encounters at an oncology Urgent Care Clinic (UCC) from a single tertiary center for upper aerodigestive malignancies from 1 July 2018 to 30 June 2019. Data were summarized using descriptive statistics with odds ratios for associations between patient features and hospitalization after UCC evaluation. Results: We identified 494 encounters from 289 individual patients over the study period. A history of ICI therapy was noted in 34% (n = 170/494) of encounters and 29 encounters (29/170, 17%) were confirmed and treated as irAEs. For those treated for irAEs, the majority (n = 19/29; 66%) were discharged home. Having an irAE was associated with an increased risk of hospitalization compared to non-irAEs (OR 5.66; 95% CI 2.15–14.89; p < 0.001). Conclusion: In this single institution experience, the majority of UCC encounters for confirmed irAEs were safely managed within the UCC. In ICI-treated patients, having an irAE was associated with an increased risk of hospitalization versus non-irAEs. |
format | Online Article Text |
id | pubmed-9221771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92217712022-06-24 An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis Liang, Kai-li Tackett, Sean Myers, Samantha Brahmer, Julie R. Browner, Ilene S. Ettinger, David S. Forde, Patrick M. Hales, Russell K. Hann, Christine L. Lam, Vincent K. Marrone, Kristen A. Patel, Tricia Peterson, Valerie Sagorsky, Sarah Turner, Michelle Voong, Khinh R. Naidoo, Jarushka Feliciano, Josephine L. Curr Oncol Article Introduction: With the increasing use of immune checkpoint inhibitors (ICI) for cancer, there is a growing burden on the healthcare system to provide care for the toxicities associated with these agents. Herein, we aim to identify and describe the distribution of encounters seen in an urgent care setting for immune-related adverse events (irAEs) and the clinical outcomes from irAE management. Methods: Patient demographics, disease characteristics, and treatment data were collected retrospectively from encounters at an oncology Urgent Care Clinic (UCC) from a single tertiary center for upper aerodigestive malignancies from 1 July 2018 to 30 June 2019. Data were summarized using descriptive statistics with odds ratios for associations between patient features and hospitalization after UCC evaluation. Results: We identified 494 encounters from 289 individual patients over the study period. A history of ICI therapy was noted in 34% (n = 170/494) of encounters and 29 encounters (29/170, 17%) were confirmed and treated as irAEs. For those treated for irAEs, the majority (n = 19/29; 66%) were discharged home. Having an irAE was associated with an increased risk of hospitalization compared to non-irAEs (OR 5.66; 95% CI 2.15–14.89; p < 0.001). Conclusion: In this single institution experience, the majority of UCC encounters for confirmed irAEs were safely managed within the UCC. In ICI-treated patients, having an irAE was associated with an increased risk of hospitalization versus non-irAEs. MDPI 2022-06-17 /pmc/articles/PMC9221771/ /pubmed/35735456 http://dx.doi.org/10.3390/curroncol29060347 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liang, Kai-li Tackett, Sean Myers, Samantha Brahmer, Julie R. Browner, Ilene S. Ettinger, David S. Forde, Patrick M. Hales, Russell K. Hann, Christine L. Lam, Vincent K. Marrone, Kristen A. Patel, Tricia Peterson, Valerie Sagorsky, Sarah Turner, Michelle Voong, Khinh R. Naidoo, Jarushka Feliciano, Josephine L. An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis |
title | An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis |
title_full | An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis |
title_fullStr | An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis |
title_full_unstemmed | An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis |
title_short | An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis |
title_sort | oncology urgent care clinic for the management of immune-related adverse events: a descriptive analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221771/ https://www.ncbi.nlm.nih.gov/pubmed/35735456 http://dx.doi.org/10.3390/curroncol29060347 |
work_keys_str_mv | AT liangkaili anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT tackettsean anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT myerssamantha anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT brahmerjulier anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT brownerilenes anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT ettingerdavids anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT fordepatrickm anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT halesrussellk anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT hannchristinel anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT lamvincentk anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT marronekristena anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT pateltricia anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT petersonvalerie anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT sagorskysarah anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT turnermichelle anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT voongkhinhr anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT naidoojarushka anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT felicianojosephinel anoncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT liangkaili oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT tackettsean oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT myerssamantha oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT brahmerjulier oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT brownerilenes oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT ettingerdavids oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT fordepatrickm oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT halesrussellk oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT hannchristinel oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT lamvincentk oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT marronekristena oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT pateltricia oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT petersonvalerie oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT sagorskysarah oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT turnermichelle oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT voongkhinhr oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT naidoojarushka oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis AT felicianojosephinel oncologyurgentcareclinicforthemanagementofimmunerelatedadverseeventsadescriptiveanalysis |